Merck

Two late-stage studies published Wednesday in The Lancet show that Astra's Imfinzi and Merck's Keytruda delayed the progress of liver cancer when combined with other drugs and a local treatment

Over the years, Singh has taken on several leadership roles in commercial organisations such as Sigma-Aldrich and Merck India

Renal cell carcinoma (RCC), the most common type of kidney cancer, predominantly affects men and has limited treatment options, often leaving patients at risk of recurrence

Some 40-50 firms in India are getting into mRNA technology, says Aditya Sharma, senior executive of the German company

Findings adds weight to earlier work by the same team of researchers that suggested that drug-induced mutations of Covid were spreading in some populations, although not in great numbers

Merck is suing the federal government over a plan to negotiate Medicare drug prices, calling the programme a sham equivalent to extortion. The drugmaker is seeking to halt the programme, which was laid out in the Inflation Reduction Act and is expected to save taxpayers billions of dollars in the coming years. Merck said in a complaint filed Tuesday that the programme does not involve genuine negotiation. Instead, it said the U.S. Department of Health and Human Services selects drugs to be included and then dictates the price, threatening drugmakers with a ruinous daily excise tax if they decline to agree. It is tantamount to extortion, the drugmaker said in the complaint, which was filed in the U.S. District Court for the District of Columbia. The drugmaker added that it expects its diabetes treatment Januvia to be part of the IRA's scheme starting later this year. Representatives of the federal agency did not immediately respond to requests for comment from The Associated Press

Merck's anti-diabetic molecule sitagliptin retains 81% market share in value terms

In India there are between 8-10 million people with heart failure, making it one of the world's largest populations with the malady

Seagen has several clinical-stage oncology candidates, as well as four approved drugs including breast cancer therapy Tukysa

The study was jointly conducted by a team of doctors at Fortis C-DOC, G.D Hospital and Diabetes Institute, Jawaharlal Nehru Medical College and Hospital, and the Diabetes Foundation

The blockbuster cancer treatment Keytruda pushed Merck past fourth-quarter expectations, and the drugmaker's COVID-19 treatment debuted with nearly $1 billion in sales. Sales for the Gardasil vaccine, which protects against cancer-causing human papilloma virus infections, jumped 50%, Merck said Thursday. Merck earned $3.75 billion in the final quarter of 2021 and sales jumping 24% to $13.52 billion. Adjusted earnings, which exclude items like interest expense, totalled $1.80 per share, far exceeding Wall Street's per-share projections of $1.53, according to a survey by the data firm FactSet. Merck sales also topped the quarterly revenue expectations of $13.16 billion from industry analysts. The drugmaker expects adjusted earnings of $7.12 to $7.27 per share on $56.1 billion to $57.6 billion in revenue. Wall Street has been projecting earnings of $7.30 per share on $56.71 billion in revenue. Shares of Merck & Co., based in Kenilworth, New Jersey, slipped 17 cents to $81.84 in ear

US drug firm defends its drug amid concerns over safety

2,510 new Covid cases reported in Mumbai on Wednesday, 82% higher than Tuesday, while Delhi reports 86% jump at 923 new infections

150 mn doses of Corbevax, Covovax expected monthly from March

Oral medication targets ribonucleic acid polymerase, a part of the virus that has not changed much after mutations in the Omicron variant.

A Food and Drug Administration panel voted 13-10 that the drug's benefits outweigh its risks, including potential birth defects if used during pregnancy

The European Medicines Agency said it has received a request from Merck to authorise its coronavirus antiviral, the first pill shown to treat COVID-19.

US advisors to meet this month to vote on authorisation

Merck has said it can produce 10 million treatment courses through the end of the year, but much of that supply has already been purchased by governments worldwide

The pharmaceutical company Merck says it has asked the European Medicines Agency to authorize its COVID-19 antiviral treatment, the first pill that has been shown to treat the disease